Login

Elis, Rings European Trading Day in Paris | Xavier Martiré - Chairman of the Management Board and Chief Executive Officer of Elis SA 00:10:00

Share On Facebook Share On Twitter

Xavier Martire is Chairman-Mgmt Board/CEO at Elis SA.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Rover Metals: Advancing Lithium, Zinc, and Copper Projects in Northern Canada and Nevada
00:10:00
Helps company in a large number of startups|Garry Tan,Partner,Y Combinator
00:10:00
RS Minerals Announces Key Soil Results and New License Acquisition in Kazakhstan
00:10:00
Raízen CEO Advocates Leadership Engagement for Corporate Transformation | Ricardo Mussa, CEO , Raízen SA.
00:10:00
Unlocking Earth's Secrets from Above: The Science of Airborne Geophysics | Dayk Mühendislik , Founder of DAYK GROUP
00:10:00
Company will focus on the continued development and commercialization of T cell therapies|Peter L. Hoang,CEO,TapImmune Inc
00:10:00
Yukon Project Generator: Diverse Opportunities with Strong Risk-Reward Potential
00:10:00
John Inch of Gordon Haskett provides in-depth insights on market trends and investment strategies in this full interview.
00:10:00
Chairman Oliver Hasler Discusses PYX Resources’ 1H24 Performance and Strategy | Oliver Hasler, Chairman , PYX Resources Ltd.
00:10:00
Advancements in Genetic Testing and Tumor Profiling for Uveal Melanoma Management |Derek J Maetzold, CEO, Castle Biosciences Inc.
00:10:00
Planning for Life: Alfredo Egydio Setubal Interview | Alfredo Egydio Setubal - President of Dexco SA
00:10:00
Inside Cartherics: A Comprehensive 5-Minute Investor Overview|Professor Alan Trounson ,CEO,CARTHERICS

© 2017 - Neuhu+